Abstract
Purpose
To investigate the efficacy and safety of aldosterone antagonist, eplerenone in the treatment of spironolactone-induced painful gynaecomastia in cirrhotic patients.
Methods
A number of 19 consecutive patients with cirrhosis due to alcohol abuse or chronic hepatitis B, who had been administered spironolactone and suffered from painful gynaecomastia, have been included in the study. Substitution of spironolactone with eplerenone was followed for 3 months under close inspection. Age and gender, along with Child–Pugh stage of cirrhosis, pain (in a 1–5 visual analogue scale), Na+, K+, FSH, LH, 17 (OH) progesterone, DHEA-S, testosterone, and prolactin were measured at the beginning and the end of the study.
Results
All 19 patients expressed alleviation of pain (P < 0.001). Two patients deteriorated and two other ameliorated as far as the Child–Pugh score is referred. All biochemical and hormonal parameters remained unchanged.
Conclusion
In cirrhotic patients with painful gynaecomastia, the use of eplerenone instead of spironolactone might reverse pain and seems to be safe and clinically acceptable option.
Similar content being viewed by others
References
Mimidis K, Papadopoulos V, Kartalis G. Eplerenone relieves spironolactone-induced painful gynaecomastia in patients with decompensated hepatitis B-related cirrhosis. Scand J Gastroenterol 2007;42(12):1516–1517
Karagiannis A, Tziomalos K, Kakafika A, et al. Eplerenone relieves spironolactone-induced painful gynaecomastia in a patient with primary aldosteronism. Nephrol Dial Transplant 2007;22:293
Pitt B, Williams G, Remme W, et al. The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone post-AMI heart failure efficacy and survival study. Cardiovasc Drugs Ther 2001;15:79–87
Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators. N Engl J Med 1999;341:709–717
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dimitriadis, G., Papadopoulos, V. & Mimidis, K. Eplerenone reverses spironolactone-induced painful gynaecomastia in cirrhotics. Hepatol Int 5, 738–739 (2011). https://doi.org/10.1007/s12072-010-9235-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12072-010-9235-x